NCT06016920
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06016920
Title Safety and Efficacy of VB10.16 and Pembrolizumab in Patients With Head-Neck Squamous Cell Carcinoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Nykode Therapeutics ASA
Indications
Therapies
Age Groups: adult | senior
Covered Countries POL | NOR | HUN | GBR | FRA | ESP | DEU

Facility Status City State Zip Country Details
CRLC Val d'Aurelle - Institut de Recherche en Cancerologie de Montpellier (IRCM) RECRUITING Montpellier 34298 France Details
Institut Gustave Roussy RECRUITING Paris France Details
Universitaetsklinikum Giessen und Marburg GmbH - Klinik fuer Hals, Nasen- und Ohrenheilkunde RECRUITING Giessen Germany Details
National Institute of Oncology RECRUITING Budapest Hungary Details
University of Bergen, Haukeland University Hospital RECRUITING Bergen Norway Details
Oslo Universitetssykehus RECRUITING Oslo Norway Details
Uniwersyteckie Cetrum Kliniczne RECRUITING Gdansk Poland Details
Narodowy Instytut Onkologii-im Marii Sklodowskiej-Curie Panstwowy Instytut RECRUITING Gliwice Poland Details
Hospital del Mar RECRUITING Barcelona Spain Details
ICO Hospitalet (Hospital Duran i Reynals) RECRUITING Barcelona Spain Details
MD Anderson Cancer Center RECRUITING Madrid Spain Details
East and North Hertfordshire NHS Trust Mount Vernon Hospital RECRUITING London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field